Drug intelligence / Profile preview

ectoine

Development stage
Unknown
Lead developer
Bitop
Modality
Small Molecules
Administration
Intranasal
01

Overview

Bentrio (AM-301) is a preservative-free, drug-free nasal spray developed by Altamira Therapeutics and licensed to Nuance Pharma for the Greater China market. It is designed to protect against airborne allergens and viruses. The formulation contains ectoine, a natural extremolyte that forms a protective hydration film (the Ectoin Hydro Complex) on the nasal mucosa. This physical barrier traps inhaled particles such as pollen, house dust mites, and viruses (including SARS-CoV-2 and influenza), preventing them from contacting and infecting the nasal epithelium. By providing a mechanical shield and moisturizing the nasal lining, Bentrio alleviates allergic symptoms and reduces the risk of viral respiratory infections. It is classified as a medical device in several jurisdictions due to its physical mode of action.

Brand names
Bentrio
Other names
Ectoin

Beyond the preview

Go deeper on ectoine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ectoine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call